Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

JNK-regulated phosphoproteome links synaptic and metabolic pathways to mood regulation

Hong, Ye; Siino, Valentina; Flinkman, Dani; Deshpande, Prasannakumar; Martinez, Sylvia Ortega; Fagerholm, Veronica; Varidaki, Artemis; Heemeryck, Pierre; Sourander, Christel; James, Peter; Coffey, Eleanor

JNK-regulated phosphoproteome links synaptic and metabolic pathways to mood regulation

Hong, Ye
Siino, Valentina
Flinkman, Dani
Deshpande, Prasannakumar
Martinez, Sylvia Ortega
Fagerholm, Veronica
Varidaki, Artemis
Heemeryck, Pierre
Sourander, Christel
James, Peter
Coffey, Eleanor
Katso/Avaa
1-s2.0-S0969996125004243-main.pdf (8.611Mb)
Lataukset: 

Elsevier BV
doi:10.1016/j.nbd.2025.107207
URI
https://doi.org/10.1016/j.nbd.2025.107207
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe202601216068
Tiivistelmä

c-Jun N-terminal kinases (JNKs) are implicated in both neurodegeneration and mood regulation, including anxiety and depressive-like behaviours. Yet the consequences of JNK inhibition in vivo on protein phosphorylation in the brain remain largely unknown. This study aimed to (1) determine how chronic JNK inhibition altered proteome-wide phosphorylation in hippocampus and nucleus accumbens, regions central to affective processing, and (2) determine which JNK-regulated phosphoproteins were associated with the anxiolytic response, representing potential drivers. Mice underwent intracerebral (ICV) infusion with DJNKI-1 or control TAT peptide for six weeks, after which behaviours were assessed and phosphoproteomic profiling performed. JNK inhibition reduced anxiety-like behaviour and significantly altered 163 and 97 phosphosites in the hippocampus and nucleus accumbens, respectively. JNK-regulated phosphoproteins were enriched for regulators of cytoskeleton organization and synaptic function. GSK3 signalling was inhibited by DJNKI-1, leading to extensive depletion of phosphorylation on GSK3 motifs within the hippocampus and nucleus accumbens. These affected proteins involved in adhesion, cytoskeleton, proteostasis and synaptic activity. Moreover, several energy metabolism proteins exhibited phosphorylation changes on sites that control their enzymatic activity. The predicted net effect is a metabolic shift from oxidative phosphorylation to anaerobic glycolysis. Network analysis revealed enhanced phosphoproteome connectivity in mice displaying low anxiety-like behaviour, with spectrin-α/β, syntaxin-1b, CRMP2 and MAPT emerging as central hubs. Notably, claudin-11, an oligodendrocyte-specific, tight junction protein, was identified as a novel phospho-target that was highly reduced upon DJNKI-1 treatment. Together, these findings highlight potential molecular markers of anxiolytic response and suggest synaptic and metabolic interplay in mood regulation.

Kokoelmat
  • Rinnakkaistallenteet [29337]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste